Taxus Cardium Pharmaceuticals Group Inc (OTC Pink - Limited Information:CRXM)

0.50
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
0.07
Today|||52-Week Range
0.78
+182.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues244.5K0.00785.3K109.2K
 
 
 
 
Cost of Goods Sold0.000.00156.5K0.00
 
 
Depreciation And Amortization180.4K194.7K280.5K269.1K
 
 
 
 
 
 
Operating ExpensesGross Income64.1K-194.7K348.3K-159.9K
 
 
 
 
 
General Expenses6.8M7.2M8.7M6.7M
 
 
 
 
 
Research And Development2.3M2.6M2.6M2.0M
 
 
 
 
 
Total Operating Expenses7.0M7.4M9.2M7.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.8M-7.4M-8.4M-6.9M
 
 
 
 
 
Extraordinary Credit2.0M283.1K64.2K0.00
 
 
 
 
Interest Expense On Debt3.0K5.5K4.2K0.00
 
 
 
 
Other Expenses0.000.000.00-771.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-7.1M-8.3M-6.9M
 
 
 
 
 
Preferred Dividend0.000.000.00-405.9K
 
 
Discontinued Operations0.000.000.00-2.0M
 
 
Net Income-4.7M-7.1M-8.3M-8.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.7M4.3M5.9M7.0M
 
 
 
 
 
Shares To Calculate EPS Diluted3.7M4.3M5.9M7.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.20-$1.60-$1.40-$1.33
 
 
 
 
 
EPS Diluted-$1.20-$1.60-$1.41-$1.33
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account